Skip to Content

Ad26.COV2-S FDA Approval Status

FDA Approved: No (Emergency Use Authorization)
Brand name: Ad26.COV2-S
Generic name: SARS-CoV-2 vaccine
Dosage form: Injection
Company: Janssen Pharmaceuticals, Inc.
Treatment for: Prevention of COVID-19

Ad26.COV2-S is an investigational vaccine against SARS-CoV-2 in development for the prevention of COVID-19.